Egis Heads for Three-Year Low as Tradewinds Global Sells Shares
Egis Gyogyszergyar Nyrt. (EGIS), a Hungarian drugmaker owned by Laboratoires Servier, headed for the lowest in three years after saying that Tradewinds Global Investors LLC cut its stake in the company to below 5 percent.
The shares dropped 0.8 percent to 13,865 forint by 10:09 a.m. in Budapest, the lowest on a closing basis since May 2009. Los Angeles-based Tradewinds’ stake in the company dropped below 10 percent in March, according to an earlier statement.
To contact the reporter on this story: Andras Gergely in Budapest at firstname.lastname@example.org
To contact the editor responsible for this story: Gavin Serkin at email@example.com
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.